Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2026

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	September 30, 2026		December 31, 2025
Prepaid research and development	$	1,845	$	2,460
Prepaid clinical trial		590		866
Deferred offering costs		110		195
Prepaid insurance		17		108
Other		659		802
Total prepaid expenses and other current assets	$	3,221	$	4,431

Schedule of Property Plant and Equipment Net

Property, plant and equipment, net consisted of the following (in thousands):

	September 30, 2026			December 31, 2025
Leasehold improvements	$	2,195		$	2,152
Laboratory equipment		3,299			3,306
Computer equipment		824			749
Furniture and fixtures		921			921
Construction in progress		421			4,292
		7,660			11,420
Accumulated depreciation		(5,134	)		(4,684	)
Property, plant and equipment, net	$	2,526		$	6,736

Schedule of Accrued Expense and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	September 30, 2026		December 31, 2025
Accrued compensation	$	7,721	$	9,425
Accrued research and development		3,622		3,591
Accrued clinical trial		3,183		3,290
Lease liabilities, current portion		1,157		1,865
Accrued professional and consulting fees		1,125		1,310
Accrued property, plant and equipment		35		19
Other		515		777
Total accrued expenses and other current liabilities	$	17,358	$	20,277